Guardant Health, Inc. - Common Stock (NQ:GH)

177.80 +3.05 (+1.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

54 Biggest Movers From Friday ↗

October 04, 2021

Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....

Via Benzinga

Why Guardant Health Is Down More Than 14% Friday ↗

October 01, 2021

Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 01, 2021

Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...

Via Benzinga

Guardant Health Weighing NeoGenomics Acquisition: Bloomberg ↗

October 01, 2021

Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar...

Via Benzinga

Analyzing Guardant Health's Unusual Options Activity ↗

August 05, 2021

Guardant Health (NASDAQ:GH) shares experienced unusual opti...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Investing in These 2 Top Stocks Could Make You a Millionaire Retiree ↗

September 30, 2021

Both of these companies boast exciting growth prospects.

Via The Motley Fool

Topics Retirement

Guardant Health Showcases Data at ESMO 2021 Demonstrating Utility of Guardant360® Liquid Biopsy to Obtain Comprehensive Molecular Information to Guide Targeted Therapy Options for Late-Stage Cancers

September 15, 2021

From Guardant Health, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 10, 2021

Gainers Hepion Pharmaceuticals (NASDAQ:HEPA

Via Benzinga

Return on Capital Employed Insights for Guardant Health ↗

September 01, 2021

After pulling data from Benzinga Pro it seems like during Q2, Guardant Health's (NASDAQ:GH) reported sales totaled $92.10 million. Despite a 9.48% in earnings, the company posted...

Via Benzinga

Guardant Health Expands Precision Oncology Offerings ↗

August 11, 2021

Guardant’s Q2 revenues grew 39% over the year to $92.1 million, ahead of the Street’s forecast by 8.8%. On an adjusted basis, it reported a loss of $0.96 per share, falling below the Street’s estimates...

Via Talk Markets

Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit

August 06, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health, inc (GH) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

GH earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Precision Oncology Sales Boost Guardant Health Q2 Topline, Backs FY21 Outlook, Management Updates ↗

August 06, 2021

After the market close on Thursday, Guardant Health Inc (NASDAQ: GH) reported Q2 revenues increased 39% Y/Y to $92.1 million, beating the consensus of $84.61...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 05, 2021

Gainers Sensus Healthcare (NASDAQ:SRTS) ...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Guardant Health Announces New Leadership Structure Aligned with Strategic Growth Objectives and Expands Board of Directors

August 05, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health Reports Second Quarter 2021 Financial Results

August 05, 2021

From Guardant Health, Inc.

Via Business Wire

Fight Colorectal Cancer and Guardant Health Join Forces to Recognize Excellence in Overcoming Challenges to Colorectal Cancer Screening During Pandemic

July 20, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Second Quarter Financial Results on August 5, 2021

July 13, 2021

From Guardant Health, Inc.

Via Business Wire

This Explosive Biotech Is Taking On a Huge New Market ↗

June 30, 2021

Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.

Via The Motley Fool

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Guardant Health Expands Guardant360® Portfolio With New Tests for Treatment Response Monitoring and Complete Genomic Profiling

June 22, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health Insights: Return On Capital Employed ↗

June 21, 2021

During Q1, Guardant Health's (NASDAQ:GH) reported sales totaled $78.67 million. Despite a 18.31% in earnings, the company posted a loss of $107.86 million. Guardant Health...

Via Benzinga

CORRECTING and REPLACING Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test Predicts Risk for Colorectal Cancer Recurrence with Industry-Leading Sensitivity

June 18, 2021

From Guardant Health

Via Business Wire

CORRECTING and REPLACING Guardant Health Presents Data at 2021 ASCO Annual Meeting Showing Utility of Liquid Biopsy in Early- and Late-Stage Cancers

June 18, 2021

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021 ↗

June 15, 2021

Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an...

Via Benzinga

Cathie Wood, Bullish On SpaceX Partner Velo3D, Buys More SPFR Shares, Adds Vertex On Dip ↗

June 13, 2021

Cathie Wood-led Ark Investment Management on Friday bought 25,000 shares, estimated to be worth about $250,000, in Jaws Spitfire Acquisition Corp (NYSE: SPFR), the blank-check...

Via Benzinga

Guardant Health Announces Appointment of Chris Freeman as Chief Commercial Officer

June 08, 2021

From Guardant Health, Inc.

Via Business Wire

Guardant Health: Return On Capital Employed Insights ↗

June 04, 2021

In Q1, Guardant Health (NASDAQ:GH) posted sales of $78.67 million. Earnings were up 18.31%, but Guardant Health still reported an overall loss of $107.86 million. Guardant Health...

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.